Unfavourable benefit-risk ratio for the active substance fenspiride, causing a potential, real and highly probable risk to patients' health or life, justifying immediate suspension and prohibition of placing the product on the market. Potential effects: serious adverse reactions, complications, life‑threatening events.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Fenspogal. Patients should check the medicine name and, if they have this product, discontinue its use and consult a doctor to determine further treatment.
The Chief Pharmaceutical Inspector imposed a temporary ban on placing Fenspogal on the market and suspended the distribution of all batches, granting the decision immediate enforceability; the marketi...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related